Cleared Traditional

K152160 - Navik 3D

K152160 is an FDA 510(k) clearance for Navik 3D, manufactured by Apn Health, LLC. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 204-day FDA review.

K152160 · Apn Health, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2016
Decision
204d
Days
Class 2
Risk

K152160 is an FDA 510(k) clearance for the Navik 3D. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Apn Health, LLC (Pleasanton, US). The FDA issued a Cleared decision on February 23, 2016 after a review of 204 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Apn Health, LLC devices

FDA 510(k) Submission Details - K152160

510(k) Number K152160 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 03, 2015
Decision Date February 23, 2016
Days to Decision 204 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
79d slower than avg
Panel avg: 125d · This submission: 204d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 271
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K152160.
Ensite Velocity Cardiac Mapping System v5.0, Ensite Automap Module v1.0
K160187 · St Jude Medical · Oct 2016
EnSite Velocity Surface Electrode Kit
K160186 · St Jude Medical · Oct 2016
CardioConfirm
K161465 · Mortara Instrument, Inc. · Sep 2016
Holter System
K151787 · Edan Instruments, Inc. · Jan 2016
MUSE Cardiology Information System
K152993 · Ge Medical Systems Information Technologies, Inc. · Jan 2016
WorkMate Claris System, WorkMate Claris System Display Plus
K151911 · St Jude Medical · Oct 2015